KBIO COMPANY Statistics

Total Valuation

KBIO COMPANY has a market cap or net worth of KRW 30.38 billion. The enterprise value is 44.10 billion.

Market Cap	30.38B
Enterprise Value	44.10B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

KBIO COMPANY has 115.50 million shares outstanding. The number of shares has increased by 25.84% in one year.

Current Share Class	n/a
Shares Outstanding	115.50M
Shares Change (YoY)	+25.84%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	77.21M

Valuation Ratios

The trailing PE ratio is 19.49.

PE Ratio	19.49
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.46
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 104.99, with an EV/FCF ratio of -23.32.

EV / Earnings	28.23
EV / Sales	0.76
EV / EBITDA	104.99
EV / EBIT	n/a
EV / FCF	-23.32

Financial Position

The company has a current ratio of 8.99, with a Debt / Equity ratio of 0.03.

Current Ratio	8.99
Quick Ratio	7.17
Debt / Equity	0.03
Debt / EBITDA	7.79
Debt / FCF	-1.73
Interest Coverage	-3.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	1.77B
Profits Per Employee	47.34M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.22% in the last 52 weeks. The beta is -0.24, so KBIO COMPANY's price volatility has been lower than the market average.

Beta (5Y)	-0.24
52-Week Price Change	+5.22%
50-Day Moving Average	246.38
200-Day Moving Average	268.57
Relative Strength Index (RSI)	50.48
Average Volume (20 Days)	11,300,673

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KBIO COMPANY had revenue of KRW 58.32 billion and earned 1.56 billion in profits. Earnings per share was 13.23.

Revenue	58.32B
Gross Profit	8.27B
Operating Income	-505.08M
Pretax Income	3.61B
Net Income	1.56B
EBITDA	419.99M
EBIT	-505.08M
Earnings Per Share (EPS)	13.23

Full Income Statement

Balance Sheet

The company has 45.91 billion in cash and 3.27 billion in debt, giving a net cash position of 42.63 billion or 369.13 per share.

Cash & Cash Equivalents	45.91B
Total Debt	3.27B
Net Cash	42.63B
Net Cash Per Share	369.13
Equity (Book Value)	122.75B
Book Value Per Share	574.88
Working Capital	57.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.82 billion and capital expenditures -67.47 million, giving a free cash flow of -1.89 billion.

Operating Cash Flow	-1.82B
Capital Expenditures	-67.47M
Free Cash Flow	-1.89B
FCF Per Share	-16.37

Full Cash Flow Statement

Margins

Gross margin is 14.18%, with operating and profit margins of -0.87% and 2.68%.

Gross Margin	14.18%
Operating Margin	-0.87%
Pretax Margin	6.18%
Profit Margin	2.68%
EBITDA Margin	0.72%
EBIT Margin	-0.87%
FCF Margin	n/a

Dividends & Yields

KBIO COMPANY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.84%
Shareholder Yield	-25.84%
Earnings Yield	5.03%
FCF Yield	-6.23%

Stock Splits

The last stock split was on April 27, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 27, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

KBIO COMPANY has an Altman Z-Score of 2.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.44
Piotroski F-Score	n/a